Bio Preventive Medicine Corp. (TPEX:6810)
Taiwan · Delayed Price · Currency is TWD 26.20
-0.30 (-1.13%)
At close: May 8, 2026
Bio Preventive Medicine Market Cap
Bio Preventive Medicine has a market cap or net worth of 1.3 billion as of May 8, 2026. Its market cap has increased by 11.97% in one year.
Market Cap
1.30B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
26.20
Market Cap Chart
Since August 30, 2021, Bio Preventive Medicine's market cap has increased from 711.01M to 1.30B, an increase of 82.21%. That is a compound annual growth rate of 13.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.30B | 11.97% |
| Dec 31, 2025 | 1.16B | -22.00% |
| Dec 31, 2024 | 1.48B | 13.92% |
| Dec 29, 2023 | 1.30B | 8.31% |
| Dec 30, 2022 | 1.20B | -4.26% |
| Dec 30, 2021 | 1.26B | 76.61% |
| Aug 30, 2021 | 711.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Advagene Biopharma | 1.51B |
| GenMont Biotech Incorporation | 1.50B |
| NeoCore Technology | 1.40B |
| Enimmune | 1.37B |
| Abnova (Taiwan) | 1.33B |
| Meribank Biotech | 1.25B |
| BiOptic | 1.13B |
| Holy Stone Healthcare | 1.11B |